Towards Healthcare
Topical Drug Delivery Market to Expand USD 568.65 Bn by 2034

Topical Drug Delivery Market Trends Highlight Rising Skin Disorders, Digital Health, and E-Pharmacy Expansion

According to market projections, the global topical drug delivery market, valued at USD 247.3 billion in 2024, is anticipated to reach USD 568.65 billion by 2034, growing at a CAGR of 8.76% over the next decade. A widespread increase in cases of diverse skin diseases is fueling enhanced adoption of topical treatments and overall global market expansion. Whereas, favourable reimbursement policies are impacting North America’s market development. 

  • Insight Code: 6034
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The topical drug delivery market stands at USD 268.99 billion in 2025 and is expected to reach USD 568.65 billion by 2034, growing at a CAGR of 8.76% from 2024 to 2034.

North America is currently leading the topical drug delivery market due to favourable reimbursement policies and a growing geriatric population associated with skin diseases.

Some key players include Galderma, LEO Pharma, Almirall, AbbVie, and Sun Pharma.

Transdermal patches are adhesive patches that support the delivery of medication through the skin and into the bloodstream. 

Causes of skin diseases are bacteria, fungi, viruses, allergies, genetics, underlying health conditions, or environmental factors.

NIAMS, CDC, NIH, US FDA, ICMR, MedlinePlus.gov, ClinicalTrials.gov.